Yalçınkaya, Y. Et Al. 2023. Efficacy of Rituximab on Disease Activity, Severity, and Disease-Related Damage in Patients with Immunosuppressive-resistant Systemic Sclerosis. TURKISH JOURNAL OF MEDICAL SCIENCES .

Yalçınkaya, Y., Artım Esen, B., Amıkıshıyev, S., Aliyeva, N., Gül, A., Öcal, M. L., ... İnanç, M.(2023). Efficacy of Rituximab on Disease Activity, Severity, and Disease-Related Damage in Patients with Immunosuppressive-resistant Systemic Sclerosis. TURKISH JOURNAL OF MEDICAL SCIENCES .

Yalçınkaya, Yasemin Et Al. "Efficacy of Rituximab on Disease Activity, Severity, and Disease-Related Damage in Patients with Immunosuppressive-resistant Systemic Sclerosis," TURKISH JOURNAL OF MEDICAL SCIENCES , 2023

Yalçınkaya, Yasemin Et Al. "Efficacy of Rituximab on Disease Activity, Severity, and Disease-Related Damage in Patients with Immunosuppressive-resistant Systemic Sclerosis." TURKISH JOURNAL OF MEDICAL SCIENCES , 2023

Yalçınkaya, Y. Et Al. (2023) . "Efficacy of Rituximab on Disease Activity, Severity, and Disease-Related Damage in Patients with Immunosuppressive-resistant Systemic Sclerosis." TURKISH JOURNAL OF MEDICAL SCIENCES .

@article{article, author={Yasemin YALÇINKAYA Et Al. }, title={Efficacy of Rituximab on Disease Activity, Severity, and Disease-Related Damage in Patients with Immunosuppressive-resistant Systemic Sclerosis}, journal={TURKISH JOURNAL OF MEDICAL SCIENCES}, year=2023}